The US–Australia Emerging Cancer Biomedical Technologies Workshop will bring together U.S. and Australian scientists and companies working in the cancer research field to discuss challenges and needs in cutting-edge, emerging cancer biomedical technologies.
The purpose of the workshop is to explore opportunities to develop new basic-to-translational research collaborations between Australian and U.S. participants, as well as share best practices on biomedical technology commercialisation and future strategies for biomedical and bioinformatics technology development. U.S. participation will include researchers from academia, industry, the National Cancer Institute, National Science Foundation, and other U.S. science agencies.
Australian researchers are now invited to submit an expression of interest to attend and/or present.
Submission Deadline: 31 January, 2017
The workshop will be held 13–15 June 2017 at Virginia Tech Research Center, Arlington, VA
Themes include:
- Discovery Science Research Tools
- Biosensors and Diagnostic Tools
- Imaging Approaches
- Bioinspired Technologies
- Tissue Engineering
- Drug Targeting and Drug Delivery
- Technology Translation and Commercialisation
